Morgan Stanley Maintains Equal-Weight on PACCAR, Lowers Price Target to $90

Morgan Stanley analyst Courtney Yakavonis maintains PACCAR (NASDAQ:PCAR) with a Equal-Weight and lowers the price target from $98 to $90.

byBenzinga Newsdesk

April 18, 2022

1 minute read

Morgan Stanley analyst Courtney Yakavonis maintains PACCAR (NASDAQ:PCAR) with a Equal-Weight and lowers the price target from $98 to $90.

Royal Caribbean Enters The Metaverse With A Virtual Cruise Ship, Fit With NFTs

By AJ Fabino

Today, 11:48 PM

Royal Caribbean Group’s (NYSE: RCL) Celebrity Cruises has entered the metaverse, with the launch of a digital cruise ship in an experience dubbed the “Wonderverse.” The company has now filed a patent to

RCL

Aurinia Pharma Shares Quiet Amid National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (Statin-DDI)’

By Benzinga Newsdesk

Today, 11:48 PM

https://clinicaltrials.gov/ct2/show/NCT05306379

AUPH

M&A
News

Stellantis To Acquire US Auto Finance Company First Investors For $285M

By Shivani Kumaresan

Today, 11:48 PM

Stellantis NV (NYSE:STLA) has agreed to acquire First Investors Financial Services Group’s parent company, F1 Holdings Corp, in an all-cash transaction for about…

STLA

Willdan Awarded Decarbonization Master Plan For Utah State University; Financial Terms Not Disclosed

By Bill Haddad

Today, 11:48 PM

Willdan Group, Inc. (NASDAQ:WLDN) announced today that Utah State University (USU) has awarded it a contract to develop a strategic decarbonization plan for the USU central utility plant. As part of this contract,

WLDN

Morgan Stanley Maintains Equal-Weight on PACCAR, Lowers Price Target to $90

Related Posts

Royal Caribbean Enters The Metaverse With A Virtual Cruise Ship, Fit With NFTs

Aurinia Pharma Shares Quiet Amid National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin (Statin-DDI)’

Stellantis To Acquire US Auto Finance Company First Investors For $285M

Willdan Awarded Decarbonization Master Plan For Utah State University; Financial Terms Not Disclosed